Novo Nordisk
NVO
#105
Rank
$175.50 B
Marketcap
$39.42
Share price
-2.57%
Change (1 day)
-32.42%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report